These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37835475)

  • 1. Immunotherapy-Related Oral Adverse Effects: Immediate Sequelae, Chronicity and Secondary Cancer.
    Elad S; Yarom N; Zadik Y
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis.
    Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
    BMC Oral Health; 2017 Jun; 17(1):103. PubMed ID: 28662707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series.
    Shazib MA; Woo SB; Sroussi H; Carvo I; Treister N; Farag A; Schoenfeld J; Haddad R; LeBoeuf N; Villa A
    Oral Dis; 2020 Mar; 26(2):325-333. PubMed ID: 31642136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichenoid proliferative leukoplakia, lichenoid lesions with evolution to proliferative leukoplakia or a continuum of the same precancerous condition? A revised hypothesis.
    Gilligan G; Garola F; Piemonte E; Leonardi N; Panico R; Warnakulasuriya S
    J Oral Pathol Med; 2021 Feb; 50(2):129-135. PubMed ID: 33225541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xerostomia and Salivary Gland Hypofunction in Patients with Oral Lichen Planus Before and After Treatment with Topical Corticosteroids.
    Al-Janaby H; El-Sakka H; Masood M; Ashani W Mendis W; M Slack-Smith L; Parsons R; M Frydrych A
    Open Dent J; 2017; 11():155-163. PubMed ID: 28567139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies.
    Carrozzo M; Porter S; Mercadante V; Fedele S
    Periodontol 2000; 2019 Jun; 80(1):105-125. PubMed ID: 31090143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lichenoid morphology could be an early feature of oral proliferative verrucous leukoplakia.
    McParland H; Warnakulasuriya S
    J Oral Pathol Med; 2021 Feb; 50(2):229-235. PubMed ID: 33185900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.
    Klein BA; Alves FA; de Santana Rodrigues Velho J; Vacharotayangul P; Hanna GJ; LeBoeuf NR; Shazib MA; Villa A; Woo SB; Sroussi H; Sonis S; Treister NS
    Oral Dis; 2022 Jan; 28(1):9-22. PubMed ID: 34265157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral lichen planus and related lesions. What should we accept based on the available evidence?
    González-Moles MÁ; Ramos-García P
    Oral Dis; 2023 Oct; 29(7):2624-2637. PubMed ID: 36371653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphometric analysis of nuclear and cellular volumetric alterations in oral lichen planus, lichenoid lesions and normal oral mucosa using image analysis software.
    Venkatesiah SS; Kale AD; Hallikeremath SR; Kotrashetti VS
    Indian J Dent Res; 2013; 24(2):277. PubMed ID: 23965463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichenoid areas may arise in early stages of proliferative verrucous leukoplakia: A long-term study of 34 patients.
    Barba-Montero C; Lorenzo-Pouso AI; Gándara-Vila P; Blanco-Carrión A; Marichalar-Mendía X; García-García A; Pérez-Sayáns M
    J Oral Pathol Med; 2022 Jul; 51(6):573-581. PubMed ID: 35596256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Toxicities of Immune Checkpoint Inhibitor (ICI) in Melanoma Patients.
    Tong J; Kartolo A; Yeung C; Hopman W; Baetz T
    Curr Oncol; 2022 Oct; 29(10):7953-7963. PubMed ID: 36290906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up study of veterans with white and red oral mucosal lesions at Veterans Affairs Dental Clinics.
    Redman RS; Diehl SR; Jones-Richardson T; Silva RG; Yeh CK; Malley KJ; Farish SE; Duffy MB; Craig RM; Winn DM
    Clin Exp Dent Res; 2023 Feb; 9(1):82-92. PubMed ID: 36510634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral lichenoid lesions: distinguishing the benign from the deadly.
    Müller S
    Mod Pathol; 2017 Jan; 30(s1):S54-S67. PubMed ID: 28060366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports.
    Abdel-Wahab N; Shah M; Suarez-Almazor ME
    PLoS One; 2016; 11(7):e0160221. PubMed ID: 27472273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral medicine 9. Lichen planus and lichenoid lesions of the oral mucosa].
    van der Meij EH; Schepman KP; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013 Sep; 120(9):477-82. PubMed ID: 24159754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xerostomia: an immunotherapy-related adverse effect in cancer patients.
    Bustillos H; Indorf A; Alwan L; Thompson J; Jung L
    Support Care Cancer; 2022 Feb; 30(2):1681-1687. PubMed ID: 34562169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
    Rai B; Kaur J; Jacobs R; Singh J
    J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pembrolizumab-Induced Lichen Planus on the Scalp of a Patient with Non-Small-Cell Lung Carcinoma.
    Yamashita A; Akasaka E; Nakano H; Sawamura D
    Case Rep Dermatol; 2021; 13(3):487-491. PubMed ID: 34720923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?
    Duma N; Abdel-Ghani A; Yadav S; Hoversten KP; Reed CT; Sitek AN; Enninga EAL; Paludo J; Aguilera JV; Leventakos K; Lou Y; Kottschade LA; Dong H; Mansfield AS; Manochakian R; Adjei AA; Dronca RS
    Oncologist; 2019 Nov; 24(11):e1148-e1155. PubMed ID: 31036771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.